{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:29:04Z","timestamp":1790695744484,"version":"4.1.0"},"reference-count":223,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001312","name":"University of Brighton","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.bbapap.2019.05.002","type":"journal-article","created":{"date-parts":[[2019,5,12]],"date-time":"2019-05-12T01:09:16Z","timestamp":1557623356000},"page":"663-676","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":92,"title":["NQO1: A target for the treatment of cancer and neurological diseases, and a model to understand loss of function disease mechanisms"],"prefix":"10.1016","volume":"1867","author":[{"given":"Sarah K.","family":"Beaver","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel","family":"Mesa-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel L.","family":"Pey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Timson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbapap.2019.05.002_bb0005","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1186\/1479-7364-2-5-329","article-title":"Update of the NAD(P)H:quinone oxidoreductase (NQO) gene family","volume":"2","author":"Vasiliou","year":"2006","journal-title":"Hum. Genomics"},{"key":"10.1016\/j.bbapap.2019.05.002_bb0010","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0891-5849(00)00308-7","article-title":"Structure-function studies of DT-diaphorase (NQO1) and NRH: quinone oxidoreductase (NQO2)","volume":"29","author":"Chen","year":"2000","journal-title":"Free Rad. Biol. Med."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0015","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.bbabio.2016.02.013","article-title":"Structure and function of mitochondrial complex I","volume":"1857","author":"Wirth","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbapap.2019.05.002_bb0020","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.tibs.2017.01.003","article-title":"Mitochondrial complex II: at the crossroads","volume":"42","author":"Bezawork-Geleta","year":"2017","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0025","doi-asserted-by":"crossref","first-page":"6804","DOI":"10.1021\/bi300778t","article-title":"Human sulfide:quinone oxidoreductase catalyzes the first step in hydrogen sulfide metabolism and produces a sulfane sulfur metabolite","volume":"51","author":"Jackson","year":"2012","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbapap.2019.05.002_bb0030","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0003-9861(02)00273-4","article-title":"Two-electron reduction of quinones by rat liver NAD(P)H:quinone oxidoreductase: quantitative structure-activity relationships","volume":"404","author":"Anusevicius","year":"2002","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0035","doi-asserted-by":"crossref","first-page":"569","DOI":"10.18388\/abp.2006_3329","article-title":"Reduction of nitroaromatic compounds by NAD(P)H:quinone oxidoreductase (NQO1): the role of electron-accepting potency and structural parameters in the substrate specificity","volume":"53","author":"Miseviciene","year":"2006","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0040","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1006\/abbi.1997.0285","article-title":"Nitrobenzimidazoles as substrates for DT-diaphorase and redox cycling compounds: their enzymatic reactions and cytotoxicity","volume":"346","author":"Sarlauskas","year":"1997","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0045","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1039\/b713044a","article-title":"Benzimidazole- and benzothiazole-quinones: excellent substrates for NAD(P)H:quinone oxidoreductase 1","volume":"5","author":"Newsome","year":"2007","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0050","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbrc.2006.12.022","article-title":"Iron (III) reduction: a novel activity of the human NAD(P)H:oxidoreductase","volume":"353","author":"Onyenwoke","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0055","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s12012-007-9001-z","article-title":"The highly expressed and inducible endogenous NAD(P)H:quinone oxidoreductase 1 in cardiovascular cells acts as a potential superoxide scavenger","volume":"7","author":"Zhu","year":"2007","journal-title":"Cardiovasc. Toxicol."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0060","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1124\/mol.65.5.1238","article-title":"NAD(P)H:quinone oxidoreductase 1: role as a superoxide scavenger","volume":"65","author":"Siegel","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0065","doi-asserted-by":"crossref","first-page":"5780","DOI":"10.1021\/jm070396q","article-title":"Synthesis and evaluation of 3-aryloxymethyl-1,2-dimethylindole-4,7-diones as mechanism-based inhibitors of NAD(P)H:quinone oxidoreductase 1 (NQO1) activity","volume":"50","author":"Colucci","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0070","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0006-291X(82)91957-X","article-title":"Vitamin K1 hydroquinone formation catalyzed by DT-diaphorase","volume":"104","author":"Fasco","year":"1982","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0075","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3177\/jnsv.31.147","article-title":"Redox levels of intravenously administered [14C]coenzyme Q10 and coenzyme Q10-reducing activity in subcellular fractions of guinea pig liver","volume":"31","author":"Takada","year":"1985","journal-title":"J. Nutr. Sci. Vitaminol. (Tokyo)"},{"key":"10.1016\/j.bbapap.2019.05.002_bb0080","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3389\/fphys.2017.00595","article-title":"Functions of NQO1 in cellular protection and CoQ10 metabolism and its potential role as a redox sensitive molecular switch","volume":"8","author":"Ross","year":"2017","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0085","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1182\/blood-2010-08-304303","article-title":"Functional study of the vitamin K cycle in mammalian cells","volume":"117","author":"Tie","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbapap.2019.05.002_bb0090","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1042\/BJ20130639","article-title":"Assessment of the contribution of NAD(P)H-dependent quinone oxidoreductase 1 (NQO1) to the reduction of vitamin K in wild-type and NQO1-deficient mice","volume":"456","author":"Ingram","year":"2013","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0095","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0891-5849(00)00306-3","article-title":"Regulation of genes encoding NAD(P)H:quinone oxidoreductases","volume":"29","author":"Jaiswal","year":"2000","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0100","doi-asserted-by":"crossref","first-page":"14960","DOI":"10.1073\/pnas.93.25.14960","article-title":"Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene","volume":"93","author":"Venugopal","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0105","doi-asserted-by":"crossref","first-page":"8846","DOI":"10.1073\/pnas.92.19.8846","article-title":"The three-dimensional structure of NAD(P)H:quinone reductase, a flavoprotein involved in cancer chemoprotection and chemotherapy: mechanism of the two-electron reduction","volume":"92","author":"Li","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0110","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/0003-9861(76)90089-8","article-title":"Purification of DT-diaphorase by affinity chromatography. Occurrence of two subunits and nonlinear Dixon and Scatchard plots of the inhibition by anticoagulants","volume":"172","author":"Rase","year":"1976","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0115","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.abb.2017.10.020","article-title":"Thermodynamics of cooperative binding of FAD to human NQO1: implications to understanding cofactor-dependent function and stability of the flavoproteome","volume":"636","author":"Claveria-Gimeno","year":"2017","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0120","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0006-3002(62)90997-6","article-title":"DT diaphorase. I. Purification from the soluble fraction of rat-liver cytoplasm, and properties","volume":"58","author":"Ernster","year":"1962","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbapap.2019.05.002_bb0125","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1074\/jbc.270.3.1198","article-title":"DT-diaphorase. Redox potential, steady-state, and rapid reaction studies","volume":"270","author":"Tedeschi","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0130","doi-asserted-by":"crossref","first-page":"6416","DOI":"10.1016\/S0021-9258(19)42173-X","article-title":"Properties and reaction mechanism of DT diaphorase from rat liver","volume":"249","author":"Hosoda","year":"1974","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0135","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.1021\/bi035923w","article-title":"Kinetic mechanism of quinone oxidoreductase 2 and its inhibition by the antimalarial quinolines","volume":"43","author":"Kwiek","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbapap.2019.05.002_bb0140","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0083-6729(07)00004-0","article-title":"Structure, function, and mechanism of cytosolic quinone reductases","volume":"78","author":"Bianchet","year":"2008","journal-title":"Vitam. Horm."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0145","doi-asserted-by":"crossref","first-page":"22298","DOI":"10.1016\/S0021-9258(18)41669-9","article-title":"Identification of a glycine-rich sequence as an NAD(P)H-binding site and tyrosine 128 as a dicumarol-binding site in rat liver NAD(P)H:quinone oxidoreductase by site-directed mutagenesis","volume":"267","author":"Ma","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0150","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1124\/mol.56.2.272","article-title":"Molecular characterization of binding of substrates and inhibitors to DT-diaphorase: combined approach involving site-directed mutagenesis, inhibitor-binding analysis, and computer modeling","volume":"56","author":"Chen","year":"1999","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0155","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0021-9258(18)51407-1","article-title":"Studies on the hemorrhagic sweet clover disease: IV. The isolation and crystallization of the hemorrhagic agent","volume":"138","author":"Campbell","year":"1941","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0160","doi-asserted-by":"crossref","first-page":"500","DOI":"10.2174\/1389450116666150722141906","article-title":"Dicoumarol: a drug which hits at least two very different targets in vitamin K metabolism","volume":"18","author":"Timson","year":"2017","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.bbapap.2019.05.002_bb0165","doi-asserted-by":"crossref","first-page":"6372","DOI":"10.1021\/bi0600087","article-title":"The crystal structure of NAD(P)H quinone oxidoreductase 1 in complex with its potent inhibitor dicoumarol","volume":"45","author":"Asher","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbapap.2019.05.002_bb0170","article-title":"Conformational dynamics is key to understanding loss-of-function of NQO1 cancer-associated polymorphisms and its correction by pharmacological ligands","volume":"6","author":"Medina-Carmona","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0175","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1074\/jbc.270.6.2512","article-title":"Active site studies of DT-diaphorase employing artificial flavins","volume":"270","author":"Tedeschi","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0180","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1016\/0006-2952(83)90681-0","article-title":"Mechanism of ticrynafen potentiation of coumarin anticoagulant action","volume":"32","author":"Preusch","year":"1983","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0185","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1432-1033.1972.tb01685.x","article-title":"A study of the DT-diaphorase activity of warfarin-resistant rats","volume":"25","author":"Ernster","year":"1972","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0190","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.1073\/pnas.0501828102","article-title":"Inhibition of NAD(P)H:quinone oxidoreductase 1 activity and induction of p53 degradation by the natural phenolic compound curcumin","volume":"102","author":"Tsvetkov","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0195","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20180459","article-title":"NAD(P)H quinone oxidoreductase (NQO1): an enzyme which needs just enough mobility, in just the right places","volume":"39","author":"Pey","year":"2019","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0200","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/j.febslet.2014.02.063","article-title":"The two common polymorphic forms of human NRH-quinone oxidoreductase 2 (NQO2) have different biochemical properties","volume":"588","author":"Megarity","year":"2014","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0205","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/1567-1364.12167","article-title":"The Saccharomyces cerevisiae quinone oxidoreductase Lot6p: stability, inhibition and cooperativity","volume":"14","author":"Megarity","year":"2014","journal-title":"FEMS Yeast Res."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0210","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00689804","article-title":"NAD(P)H:quinone oxidoreductase1 (DT-diaphorase) expression in normal and tumor tissues","volume":"12","author":"Belinsky","year":"1993","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0215","first-page":"5513","article-title":"Dicumarol inhibition of NADPH:quinone oxidoreductase induces growth inhibition of pancreatic cancer via a superoxide-mediated mechanism","volume":"63","author":"Cullen","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0220","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.1158\/1078-0432.CCR-03-0667","article-title":"Treatment of pancreatic cancer cells with dicumarol induces cytotoxicity and oxidative stress","volume":"10","author":"Lewis","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0225","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1136\/jcp.2.1.45","article-title":"Prothrombin Time in Dicoumarol Therapy","volume":"2","author":"James","year":"1949","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0230","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1021\/jm00235a019","article-title":"Quantitative structure-activity relationships for dicoumarol antivitamins K in the uncoupling of mitochondrial oxidative phosphorylation","volume":"18","author":"Laruelle","year":"1975","journal-title":"J. Med. Chem."},{"issue":"Suppl. 1","key":"10.1016\/j.bbapap.2019.05.002_bb0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1538-7836.2007.02549.x","article-title":"VKORC1: molecular target of coumarins","volume":"5","author":"Oldenburg","year":"2007","journal-title":"J. Thrombosis Haemostasis"},{"key":"10.1016\/j.bbapap.2019.05.002_bb0240","doi-asserted-by":"crossref","first-page":"7142","DOI":"10.1021\/jm9011609","article-title":"Synthesis and biological evaluation of coumarin-based inhibitors of NAD(P)H: quinone oxidoreductase-1 (NQO1)","volume":"52","author":"Nolan","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0245","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.bcp.2010.06.024","article-title":"Pharmacological inhibitors of NAD(P)H quinone oxidoreductase, NQO1: structure\/activity relationships and functional activity in tumour cells","volume":"80","author":"Nolan","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0250","doi-asserted-by":"crossref","first-page":"6246","DOI":"10.1016\/j.bmcl.2006.09.015","article-title":"In silico identification and biochemical characterization of novel inhibitors of NQO1","volume":"16","author":"Nolan","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0255","doi-asserted-by":"crossref","first-page":"6316","DOI":"10.1021\/jm070472p","article-title":"Coumarin-based inhibitors of human NAD(P)H:quinone oxidoreductase-1. Identification, structure-activity, off-target effects and in vitro human pancreatic cancer toxicity","volume":"50","author":"Nolan","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0260","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.bcp.2010.10.011","article-title":"Inhibitors of NQO1: identification of compounds more potent than dicoumarol without associated off-target effects","volume":"81","author":"Scott","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0265","first-page":"1","article-title":"Identification of novel NAD(P)H dehydrogenase [quinone] 1 antagonist using computational approaches","author":"Selvakumar","year":"2019","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0270","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejmech.2014.05.041","article-title":"2-Substituted 3-methylnaphtho[1,2-b]furan-4,5-diones as novel L-shaped ortho-quinone substrates for NAD(P)H:quinone oxidoreductase (NQO1)","volume":"82","author":"Bian","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0275","article-title":"The inhibition kinetics and potential anti-migration activity of NQO1 inhibitory coumarins on cholangiocarcinoma cells","volume":"18","author":"Khunluck","year":"2019","journal-title":"Integrat. Cancer Therapies"},{"key":"10.1016\/j.bbapap.2019.05.002_bb0280","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ejmech.2018.05.025","article-title":"Development of novel amino-quinoline-5,8-dione derivatives as NAD(P)H:quinone oxidoreductase 1 (NQO1) inhibitors with potent antiproliferative activities","volume":"154","author":"Ling","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0285","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/cbdd.13051","article-title":"Combined molecular modelling and 3D-QSAR study for understanding the inhibition of NQO1 by heterocyclic quinone derivatives","volume":"91","author":"Lopez-Lira","year":"2018","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0290","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3727\/095535491820873164","article-title":"The role of NAD(P)H: quinone reductase (EC 1.6.99.2, DT-diaphorase) in the reductive bioactivation of the novel indoloquinone antitumor agent EO9","volume":"3","author":"Walton","year":"1991","journal-title":"Cancer Commun."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0295","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0006-2952(97)00661-8","article-title":"Reduction of the indoloquinone anticancer drug EO9 by purified DT-diaphorase: a detailed kinetic study and analysis of metabolites","volume":"56","author":"Bailey","year":"1998","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0300","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1476-5381.2012.01996.x","article-title":"EO9 (Apaziquone): from the clinic to the laboratory and back again","volume":"168","author":"Phillips","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0305","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1080\/17425255.2017.1341490","article-title":"Efficacy, pharmacokinetic and pharmacodynamic evaluation of apaziquone in the treatment of non-muscle invasive bladder cancer","volume":"13","author":"Phillips","year":"2017","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0310","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1038\/bjc.2013.357","article-title":"The NQO1 polymorphism C609T (Pro187Ser) and cancer susceptibility: a comprehensive meta-analysis","volume":"109","author":"Lajin","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbapap.2019.05.002_bb0315","doi-asserted-by":"crossref","first-page":"D48","DOI":"10.1093\/nar\/gks1236","article-title":"Ensembl 2013","volume":"41","author":"Flicek","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0320","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1146\/annurev.ge.05.120171.000341","article-title":"Malaria and human polymorphisms","volume":"5","author":"Livingstone","year":"1971","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0325","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/00008571-200306000-00006","article-title":"CYP2E1 and NQO1 genotypes, smoking and bladder cancer","volume":"13","author":"Choi","year":"2003","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.bbapap.2019.05.002_bb0330","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/mgg3.461","article-title":"Joint effect of smoking and NQO1 C609T polymorphism on undifferentiated nasopharyngeal carcinoma risk in a North African population","volume":"6","author":"Moumad","year":"2018","journal-title":"Mol. Genet. Genomic Med."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0335","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00125817-200203000-00003","article-title":"NAD(P)H:quinone oxidoreductase (NQO1) polymorphism, exposure to benzene, and predisposition to disease: a HuGE review","volume":"4","author":"Nebert","year":"2002","journal-title":"Genet. Med."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0340","doi-asserted-by":"crossref","first-page":"8150","DOI":"10.1073\/pnas.96.14.8150","article-title":"A potential mechanism underlying the increased susceptibility of individuals with a polymorphism in NAD(P)H:quinone oxidoreductase 1 (NQO1) to benzene toxicity","volume":"96","author":"Moran","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0345","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1021\/tx9902082","article-title":"Role of quinones in toxicology","volume":"13","author":"Bolton","year":"2000","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0350","doi-asserted-by":"crossref","first-page":"10368","DOI":"10.1074\/jbc.M211981200","article-title":"Interaction of human NAD(P)H:quinone oxidoreductase 1 (NQO1) with the tumor suppressor protein p53 in cells and cell-free systems","volume":"278","author":"Anwar","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0355","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1073\/pnas.98.3.1188","article-title":"Regulation of p53 stability and p53-dependent apoptosis by NADH quinone oxidoreductase 1","volume":"98","author":"Asher","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0360","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1073\/pnas.052706799","article-title":"NQO1 stabilizes p53 through a distinct pathway","volume":"99","author":"Asher","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0365","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1101\/gad.319905","article-title":"A mechanism of ubiquitin-independent proteasomal degradation of the tumor suppressors p53 and p73","volume":"19","author":"Asher","year":"2005","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0370","doi-asserted-by":"crossref","first-page":"13125","DOI":"10.1073\/pnas.202480499","article-title":"Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1","volume":"99","author":"Asher","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0375","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1023\/A:1007604414773","article-title":"NO synthase and NO-dependent signal pathways in brain aging and neurodegenerative disorders: the role of oxidant\/antioxidant balance","volume":"25","author":"Calabrese","year":"2000","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0380","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/cne.20048","article-title":"Presence and induction of the enzyme NAD(P)H: quinone oxidoreductase 1 in the central nervous system","volume":"471","author":"Stringer","year":"2004","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0385","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/0306-4522(88)90181-9","article-title":"Distribution of DT diaphorase in the rat brain: biochemical and immunohistochemical studies","volume":"27","author":"Schultzberg","year":"1988","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbapap.2019.05.002_bb0390","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1046\/j.1471-4159.1998.70052156.x","article-title":"Histochemical detection of quinone reductase activity in situ using LY 83583 reduction and oxidation","volume":"70","author":"Murphy","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0395","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1046\/j.1471-4159.1998.70010268.x","article-title":"Increased protein oxidation in human substantia nigra pars compacta in comparison with basal ganglia and prefrontal cortex measured with an improved dinitrophenylhydrazine assay","volume":"70","author":"Floor","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0400","first-page":"1086","article-title":"SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson's disease","volume":"123","author":"Xie","year":"2010","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0405","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s11357-011-9245-1","article-title":"The plasma membrane redox enzyme NQO1 sustains cellular energetics and protects human neuroblastoma cells against metabolic and proteotoxic stress","volume":"34","author":"Hyun","year":"2012","journal-title":"Age (Dordr.)"},{"key":"10.1016\/j.bbapap.2019.05.002_bb0410","article-title":"Mitochondrial function in human neuroblastoma cells is up-regulated and protected by NQO1, a plasma membrane redox enzyme","volume":"8","author":"Kim","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbapap.2019.05.002_bb0415","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.neuint.2012.02.004","article-title":"Caffeinated coffee, decaffeinated coffee, and the phenolic phytochemical chlorogenic acid up-regulate NQO1 expression and prevent H2O2-induced apoptosis in primary cortical neurons","volume":"60","author":"Kim","year":"2012","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0420","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1002\/jnr.22307","article-title":"Sulforaphane protects immature hippocampal neurons against death caused by exposure to hemin or to oxygen and glucose deprivation","volume":"88","author":"Soane","year":"2010","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0425","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/j.1471-4159.2011.07395.x","article-title":"Antioxidant mechanism of isoflavone metabolites in hydrogen peroxide-stimulated rat primary astrocytes: critical role of hemeoxygenase-1 and NQO1 expression","volume":"119","author":"Park","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0430","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.freeradbiomed.2016.05.024","article-title":"\u03b2-Lapachone increases phase II antioxidant enzyme expression via NQO1-AMPK\/PI3K-Nrf2\/ARE signaling in rat primary astrocytes","volume":"97","author":"Park","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0435","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12974-015-0355-z","article-title":"\u03b2-Lapachone suppresses neuroinflammation by modulating the expression of cytokines and matrix metalloproteinases in activated microglia","volume":"12","author":"Lee","year":"2015","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbapap.2019.05.002_bb0440","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0009-2797(89)90006-9","article-title":"On the mechanism of the Mn3+-induced neurotoxicity of dopamine:prevention of quinone-derived oxygen toxicity by DT diaphorase and superoxide dismutase","volume":"72","author":"Segura-Aguilar","year":"1989","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0445","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/BF03033177","article-title":"Effects of the DT-diaphorase inhibitor dicumarol on striatal monoamine levels in L-DOPA and L-deprenyl pre-treated rats","volume":"5","author":"Bustamante","year":"2004","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0450","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.neurobiolaging.2003.12.010","article-title":"Expression of NAD(P)H:quinone oxidoreductase in the normal and Parkinsonian substantia nigra","volume":"25","author":"van Muiswinkel","year":"2004","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbapap.2019.05.002_bb0455","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neulet.2004.11.009","article-title":"No associations between Parkinson's disease and polymorphisms of the quinone oxidoreductase (NQO1, NQO2) genes","volume":"375","author":"Okada","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0460","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1006\/bbrc.2001.5868","article-title":"An association between idiopathic Parkinson's disease and polymorphisms of phase II detoxification enzymes: glutathione S-transferase M1 and quinone oxidoreductase 1 and 2","volume":"288","author":"Harada","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0465","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s12640-017-9719-8","article-title":"On the role of DT-diaphorase inhibition in aminochrome-induced neurotoxicity in vivo","volume":"32","author":"Herrera-Soto","year":"2017","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0470","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/toxsci\/kfr060","article-title":"Autophagy protects against aminochrome-induced cell death in substantia nigra-derived cell line","volume":"121","author":"Paris","year":"2011","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0475","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s12640-009-9148-4","article-title":"Aminochrome induces disruption of actin, alpha-, and beta-tubulin cytoskeleton networks in substantia-nigra-derived cell line","volume":"18","author":"Paris","year":"2010","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0480","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1021\/tx100182a","article-title":"Stable expression of short interfering RNA for DT-diaphorase induces neurotoxicity","volume":"23","author":"Lozano","year":"2010","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0485","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s12640-018-9953-8","article-title":"DT-diaphorase prevents aminochrome-induced lysosome dysfunction in SH-SY5Y cells","volume":"35","author":"Melendez","year":"2019","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0490","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.neuropharm.2012.11.010","article-title":"L-dopa-induced dopamine synthesis and oxidative stress in serotonergic cells","volume":"67","author":"Stansley","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbapap.2019.05.002_bb0495","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.pbb.2003.10.016","article-title":"Behavioral effects of manganese injected in the rat substantia nigra are potentiated by dicumarol, a DT-diaphorase inhibitor","volume":"77","author":"Diaz-Veliz","year":"2004","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0500","article-title":"Sulforaphane protects against rotenone-induced neurotoxicity in vivo: involvement of the mTOR, Nrf2, and autophagy pathways","volume":"6","author":"Zhou","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0505","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s12031-015-0516-7","article-title":"Induction of NQO1 and neuroprotection by a novel compound KMS04014 in Parkinson's disease models","volume":"56","author":"Son","year":"2015","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0510","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.toxlet.2006.07.340","article-title":"Overexpression of NQO1 protects human SK-N-MC neuroblastoma cells against dopamine-induced cell death","volume":"166","author":"Zafar","year":"2006","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0515","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.brainres.2007.12.044","volume":"1197","author":"Jia","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0520","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.neuint.2010.07.013","article-title":"2-Phenylethylamine, a constituent of chocolate and wine, causes mitochondrial complex-I inhibition, generation of hydroxyl radicals and depletion of striatal biogenic amines leading to psycho-motor dysfunctions in Balb\/c mice","volume":"57","author":"Sengupta","year":"2010","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0525","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s12264-013-1330-2","article-title":"Contribution of beta-phenethylamine, a component of chocolate and wine, to dopaminergic neurodegeneration: implications for the pathogenesis of Parkinson's disease","volume":"29","author":"Borah","year":"2013","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0530","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.freeradbiomed.2011.04.043","article-title":"The C609T inborn polymorphism in NAD(P)H:quinone oxidoreductase 1 is associated with susceptibility to multiple sclerosis and affects the risk of development of the primary progressive form of the disease","volume":"51","author":"Stavropoulou","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0535","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1471-2377-14-87","article-title":"NQO1 gene rs1800566 variant is not associated with risk for multiple sclerosis","volume":"14","author":"Agundez","year":"2014","journal-title":"BMC Neurol."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0540","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3109\/00207454.2014.899597","article-title":"Combined GSTP1 and NQO1 germline polymorphisms in the susceptibility to Multiple Sclerosis","volume":"125","author":"Alexoudi","year":"2015","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0545","first-page":"586","article-title":"Possible implication of GSTP1 and NQO1 polymorphisms on natalizumab response in multiple sclerosis","volume":"46","author":"Alexoudi","year":"2016","journal-title":"Ann. Clin. Lab. Sci."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0550","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.freeradbiomed.2006.04.013","article-title":"NAD(P)H:quinone oxidoreductase 1 expression in multiple sclerosis lesions","volume":"41","author":"van Horssen","year":"2006","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0555","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1586\/14789450.5.2.157","article-title":"Redox proteomics: understanding oxidative stress in the progression of age-related neurodegenerative disorders","volume":"5","author":"Butterfield","year":"2008","journal-title":"Expert Rev. Proteom."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0560","first-page":"2124","article-title":"Association between NAD(P)H: quinone oxidoreductase and apolipoprotein E gene polymorphisms in Alzheimer's disease","volume":"83","author":"Ma","year":"2003","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.bbapap.2019.05.002_bb0565","first-page":"285","article-title":"NQ01 gene polymorphism C609T associated with an increased risk for cognitive dysfunction and sporadic Alzheimer's disease in Chinese","volume":"27","author":"Wan","year":"2005","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"key":"10.1016\/j.bbapap.2019.05.002_bb0570","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s12031-008-9036-z","article-title":"Association of NAD(P)H:quinone oxidoreductase 1 polymorphism and Alzheimer's disease in Chinese","volume":"34","author":"Bian","year":"2008","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0575","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.neulet.2006.09.042","article-title":"Association analysis of NAD(P)H:quinone oxidoreductase gene 609 C\/T polymorphism with Alzheimer's disease","volume":"409","author":"Wang","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0580","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1179\/135100099101534701","article-title":"Quinone reductase (NQO1), a sensitive redox indicator, is increased in Alzheimer's disease","volume":"4","author":"Raina","year":"1999","journal-title":"Redox Rep."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0585","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0197-4580(03)00117-9","article-title":"Regional NAD(P)H:quinone oxidoreductase activity in Alzheimer's disease","volume":"25","author":"SantaCruz","year":"2004","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbapap.2019.05.002_bb0590","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.bbr.2014.04.055","article-title":"Neophobia, NQO1 and SIRT1 as premorbid and prodromal indicators of AD in 3xTg-AD mice","volume":"271","author":"Torres-Lista","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0595","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jff.2017.09.025","article-title":"Cyanidin-3-O-glucoside attenuates amyloid-beta (1\u201340)-induced oxidative stress and apoptosis in SH-SY5Y cells through a Nrf2 mechanism","volume":"38","author":"Meng","year":"2017","journal-title":"J. Funct. Foods"},{"key":"10.1016\/j.bbapap.2019.05.002_bb0600","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1172\/JCI29715","article-title":"The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins","volume":"117","author":"Dickey","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0605","doi-asserted-by":"crossref","first-page":"8839","DOI":"10.1074\/jbc.M110.193276","article-title":"E3 ligase STUB1\/CHIP regulates NAD(P)H:quinone oxidoreductase 1 (NQO1) accumulation in aged brain, a process impaired in certain Alzheimer disease patients","volume":"286","author":"Tsvetkov","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0610","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.expneurol.2010.07.020","article-title":"The plasma membrane redox system is impaired by amyloid beta-peptide and in the hippocampus and cerebral cortex of 3xTgAD mice","volume":"225","author":"Hyun","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0615","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0920-9964(97)00005-4","article-title":"Oxidative reactions and schizophrenia: a review-discussion","volume":"24","author":"Smythies","year":"1997","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0620","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1089\/ars.2010.3646","article-title":"Oxidative stress in schizophrenia: pathogenetic and therapeutic implications","volume":"15","author":"Yao","year":"2011","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0625","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/10298420290015827","article-title":"The adrenochrome hypothesis of schizophrenia revisited","volume":"4","author":"Smythies","year":"2002","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0630","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1017\/S1461145704004419","article-title":"Quinone oxidoreductase (NQO1) gene polymorphism (609C\/T) may be associated with tardive dyskinesia, but not with the development of schizophrenia","volume":"7","author":"Pae","year":"2004","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0635","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.pnpbp.2009.09.020","article-title":"Oxidative stress in tardive dyskinesia: genetic association study and meta-analysis of NADPH quinine oxidoreductase 1 (NQO1) and Superoxide dismutase 2 (SOD2, MnSOD) genes","volume":"34","author":"Zai","year":"2010","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbapap.2019.05.002_bb0640","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1017\/S1461145705005262","article-title":"Association analysis of NAD(P)Hratioquinone oxidoreductase (NQO1) Pro187Ser genetic polymorphism and tardive dyskinesia in patients with schizophrenia in Taiwan","volume":"8","author":"Liou","year":"2005","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0645","first-page":"287","article-title":"The cytokine hypothesis of depression: inflammation, oxidative & nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive treatments in depression","volume":"29","author":"Maes","year":"2008","journal-title":"Neuro. Endocrinol. Lett."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0650","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1017\/S1092852900016734","article-title":"Inflammation, glutamate, and glia in depression: a literature review","volume":"13","author":"McNally","year":"2008","journal-title":"CNS Spectrums"},{"key":"10.1016\/j.bbapap.2019.05.002_bb0655","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neulet.2015.04.036","article-title":"Nrf2-signaling and BDNF: A new target for the antidepressant-like activity of chronic fluoxetine treatment in a mouse model of anxiety\/depression","volume":"597","author":"Mendez-David","year":"2015","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0660","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.psychres.2006.01.011","article-title":"Quinone oxidoreductase (NQO1) gene polymorphism may not confer a susceptibility to mood disorders","volume":"153","author":"Pae","year":"2007","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0665","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.cca.2010.02.071","article-title":"Genotype polymorphisms of GGCX, NQO1, and VKORC1 genes associated with risk susceptibility in patients with large-artery atherosclerotic stroke","volume":"411","author":"Shyu","year":"2010","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bbapap.2019.05.002_bb0670","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s10072-017-2930-9","article-title":"Association of cytochrome P4502E1 and NAD(P)H:quinone oxidoreductase 1 genetic polymorphisms with susceptibility to large artery atherosclerotic ischemic stroke: a case-control study in the Turkish population","volume":"38","author":"Turkanoglu Ozcelik","year":"2017","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0675","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nature13001","article-title":"The ensemble nature of allostery","volume":"508","author":"Motlagh","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bbapap.2019.05.002_bb0680","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1146\/annurev-biochem-061516-044518","article-title":"Protein misfolding diseases","volume":"86","author":"Hartl","year":"2017","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0685","first-page":"28","article-title":"Protein misfolding and degenerative diseases","volume":"3","author":"Reynaud","year":"2010","journal-title":"Nat. Educ."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0690","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/nrg2808","article-title":"Mutational effects and the evolution of new protein functions","volume":"11","author":"Soskine","year":"2010","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0695","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.sbi.2009.08.003","article-title":"Stability effects of mutations and protein evolvability","volume":"19","author":"Tokuriki","year":"2009","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0700","doi-asserted-by":"crossref","DOI":"10.1126\/science.aac4354","article-title":"In vivo aspects of protein folding and quality control","volume":"353","author":"Balchin","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.bbapap.2019.05.002_bb0705","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev-biochem-060208-092442","article-title":"Molecular chaperone functions in protein folding and proteostasis","volume":"82","author":"Kim","year":"2013","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0710","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jmb.2007.03.069","article-title":"The stability effects of protein mutations appear to be universally distributed","volume":"369","author":"Tokuriki","year":"2007","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0715","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/hmg\/ddy323","article-title":"Insight into the specificity and severity of pathogenic mechanisms associated with missense mutations through experimental and structural perturbation analyses","volume":"28","author":"Medina-Carmona","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0720","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1126\/science.aaa9119","article-title":"The origins, determinants, and consequences of human mutations","volume":"349","author":"Shendure","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.bbapap.2019.05.002_bb0725","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1126\/science.1213491","article-title":"Fitness trade-offs and environmentally induced mutation buffering in isogenic C. elegans","volume":"335","author":"Casanueva","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.bbapap.2019.05.002_bb0730","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006739","article-title":"Predicting the impact of Lynch syndrome-causing missense mutations from structural calculations","volume":"13","author":"Nielsen","year":"2017","journal-title":"PLoS Genet."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0735","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/humu.23707","article-title":"Towards mechanistic models for genotype-phenotype correlations in phenylketonuria using protein stability calculations","volume":"40","author":"Scheller","year":"2019","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0740","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1086\/521879","article-title":"Predicted effects of missense mutations on native-state stability account for phenotypic outcome in phenylketonuria, a paradigm of misfolding diseases","volume":"81","author":"Pey","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0745","first-page":"797","article-title":"NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity","volume":"52","author":"Traver","year":"1992","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0750","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/bjc.1997.11","article-title":"Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase)","volume":"75","author":"Traver","year":"1997","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbapap.2019.05.002_bb0755","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0026-895X(24)12836-2","article-title":"Rapid polyubiquitination and proteasomal degradation of a mutant form of NAD(P)H:quinone oxidoreductase 1","volume":"59","author":"Siegel","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0760","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1101\/gad.319905","article-title":"A mechanism of ubiquitin-independent proteasomal degradation of the tumor suppressors p53 and p73","volume":"19","author":"Asher","year":"2005","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0765","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.molcel.2012.05.049","article-title":"A mutually inhibitory feedback loop between the 20S proteasome and its regulator, NQO1","volume":"47","author":"Moscovitz","year":"2012","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbapap.2019.05.002_bb0770","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/j.bbadis.2014.08.011","article-title":"FAD binding overcomes defects in activity and stability displayed by cancer-associated variants of human NQO1","volume":"1842","author":"Pey","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbapap.2019.05.002_bb0775","doi-asserted-by":"crossref","first-page":"4691","DOI":"10.1111\/febs.12975","article-title":"Collapse of the native structure caused by a single amino acid exchange in human NAD(P)H:quinone oxidoreductase(1.)","volume":"281","author":"Lienhart","year":"2014","journal-title":"FEBS J."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0780","doi-asserted-by":"crossref","first-page":"12156","DOI":"10.1073\/pnas.1611994113","article-title":"Recognition of enzymes lacking bound cofactor by protein quality control","volume":"113","author":"Mart\u00ednez-Lim\u00f3n","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0785","article-title":"Conformational dynamics is key to understanding loss-of-function of NQO1 cancer-associated polymorphisms and its correction by pharmacological ligands","volume":"6","author":"Medina-Carmona","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0790","doi-asserted-by":"crossref","DOI":"10.1038\/srep44532","article-title":"Site-to-site interdomain communication may mediate different loss-of-function mechanisms in a cancer-associated NQO1 polymorphism","volume":"7","author":"Medina-Carmona","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0795","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1002\/1873-3468.12772","article-title":"A mechanism for cancer-associated inactivation of NQO1 due to P187S and its reactivation by the consensus mutation H80R","volume":"591","author":"Munoz","year":"2017","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0800","doi-asserted-by":"crossref","first-page":"862","DOI":"10.3390\/biom4030862","article-title":"Regulating the 20S proteasome ubiquitin-independent degradation pathway","volume":"4","author":"Ben-Nissan","year":"2014","journal-title":"Biomolecules"},{"key":"10.1016\/j.bbapap.2019.05.002_bb0805","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1093\/hmg\/ddx238","article-title":"Enhanced vulnerability of human proteins towards disease-associated inactivation through divergent evolution","volume":"26","author":"Medina-Carmona","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0810","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.ijbiomac.2018.09.108","article-title":"Phosphorylation compromises FAD binding to wild-type and cancer-associated NQO1: new insights into the flavin-dependent stability of the human flavoproteome","volume":"125","author":"Medina-Carmona","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0815","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1073\/pnas.98.3.1188","article-title":"Regulation of p53 stability and p53-dependent apoptosis by NADH quinone oxidoreductase 1","volume":"98","author":"Asher","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0820","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1073\/pnas.052706799","article-title":"NQO1 stabilizes p53 through a distinct pathway","volume":"99","author":"Asher","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0825","doi-asserted-by":"crossref","first-page":"10368","DOI":"10.1074\/jbc.M211981200","article-title":"Interaction of human NAD(P)H:quinone oxidoreductase 1 (NQO1) with the tumor suppressor protein p53 in cells and cell-free systems","volume":"278","author":"Anwar","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0830","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1016\/j.ijbiomac.2018.07.051","article-title":"Biophysical and functional perturbation analyses at cancer-associated P187 and K240 sites of the multifunctional NADP(H):quinone oxidoreductase 1","volume":"118 (","author":"Pey","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0835","first-page":"330","article-title":"NAD(P)H:quinone oxidoreductase expression and mitomycin C resistance developed by human colon cancer HCT 116 cells","volume":"55","author":"Pan","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0840","first-page":"139","article-title":"Irradiation-induced p53 expression is attenuated in cells with NQO1 C465T polymorphism","volume":"57","author":"Sato","year":"2010","journal-title":"J. Med. Dent. Sci."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0845","first-page":"1511","article-title":"The association of a distinctive allele of NAD(P)H:quinone oxidoreductase with pediatric acute lymphoblastic leukemias with MLL fusion genes in Japan","volume":"90","author":"Eguchi-Ishimae","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.bbapap.2019.05.002_bb0850","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1111\/febs.14051","article-title":"Catalytic competence, structure and stability of the cancer-associated R139W variant of the human NAD(P)H:quinone oxidoreductase 1 (NQO1)","volume":"284","author":"Lienhart","year":"2017","journal-title":"FEBS J."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0855","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0140-6736(07)61209-4","article-title":"Tetrahydrobiopterin for patients with phenylketonuria","volume":"370","author":"Pey","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.bbapap.2019.05.002_bb0860","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0079-6603(08)00603-X","article-title":"Rescuing proteins of low kinetic stability by chaperones and natural ligands phenylketonuria, a case study","volume":"83","author":"Martinez","year":"2008","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0865","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.bbadis.2017.11.024","article-title":"New perspectives for pharmacological chaperoning treatment in methylmalonic aciduria cblB type","volume":"1864","author":"Brasil","year":"2018","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbapap.2019.05.002_bb0870","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1471-4159.2010.06821.x","article-title":"Effect of pharmacological chaperones on brain tyrosine hydroxylase and tryptophan hydroxylase 2","volume":"114","author":"Calvo","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0875","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.1093\/hmg\/ddv276","article-title":"Pyridoxamine and pyridoxal are more effective than pyridoxine in rescuing folding-defective variants of human alanine:glyoxylate aminotransferase causing primary hyperoxaluria type I","volume":"24","author":"Oppici","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0880","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat7467","article-title":"Repurposing ciclopirox as a pharmacological chaperone in a model of congenital erythropoietic porphyria","volume":"10","author":"Urquiza","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0885","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.2174\/1568026611212220009","article-title":"Cofactors and metabolites as protein folding helpers in metabolic diseases","volume":"12","author":"Rodrigues","year":"2012","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0890","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/164_2017_72","article-title":"Potential pharmacological chaperones for cystathionine beta-synthase-deficient homocystinuria","volume":"245","author":"Majtan","year":"2018","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0895","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nchembio.763","article-title":"Small-molecule proteostasis regulators for protein conformational diseases","volume":"8","author":"Calamini","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0900","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/gcc.22487","article-title":"Blocking protein quality control to counter hereditary cancers","volume":"56","author":"Kampmeyer","year":"2017","journal-title":"Genes Chromosom. Cancer"},{"key":"10.1016\/j.bbapap.2019.05.002_bb0905","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.2174\/1389450117666160813180812","article-title":"Therapeutic approaches using riboflavin in mitochondrial energy metabolism disorders","volume":"17","author":"J. Henriques","year":"2016","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.bbapap.2019.05.002_bb0910","doi-asserted-by":"crossref","first-page":"15428","DOI":"10.1073\/pnas.192582899","article-title":"Chemical chaperones increase the cellular activity of N370S beta -glucosidase: a therapeutic strategy for Gaucher disease","volume":"99","author":"Sawkar","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0915","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10787","article-title":"Repositioning tolcapone as a potent inhibitor of transthyretin amyloidogenesis and associated cellular toxicity","volume":"7","author":"Sant'Anna","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0920","doi-asserted-by":"crossref","first-page":"14060","DOI":"10.1074\/jbc.M111576200","article-title":"Interaction of the molecular chaperone Hsp70 with human NAD(P)H:quinone oxidoreductase 1","volume":"277","author":"Anwar","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0925","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.2174\/1389450117666160101121610","article-title":"Natural small molecules as stabilizers and activators of cancer-associated NQO1 polymorphisms","volume":"17","author":"L. Pey","year":"2016","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.bbapap.2019.05.002_bb0930","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1093\/hmg\/ddx067","article-title":"Missense UROS mutations causing congenital erythropoietic porphyria reduce UROS homeostasis that can be rescued by proteasome inhibition","volume":"26","author":"Blouin","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0935","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10239","article-title":"Tripartite degrons confer diversity and specificity on regulated protein degradation in the ubiquitin-proteasome system","volume":"7","author":"Guharoy","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0940","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/j.celrep.2014.07.055","article-title":"Intrinsically disordered segments affect protein half-life in the cell and during evolution","volume":"8","author":"van der Lee","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0945","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0026-895X(24)12836-2","article-title":"Rapid polyubiquitination and proteasomal degradation of a mutant form of NAD(P)H:quinone oxidoreductase 1","volume":"59","author":"Siegel","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0950","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.molcel.2012.05.049","article-title":"A mutually inhibitory feedback loop between the 20S proteasome and its regulator, NQO1","volume":"47","author":"Moscovitz","year":"2012","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbapap.2019.05.002_bb0955","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/164_2017_55","article-title":"Natural (and unnatural) small molecules as pharmacological chaperones and inhibitors in cancer","volume":"245","author":"Betancor-Fernandez","year":"2018","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0960","doi-asserted-by":"crossref","DOI":"10.3390\/genes9070352","article-title":"Evolutionary divergent suppressor mutations in conformational diseases","volume":"9","author":"Mesa-Torres","year":"2018","journal-title":"Genes"},{"key":"10.1016\/j.bbapap.2019.05.002_bb0965","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature15393","article-title":"A global reference for human genetic variation","volume":"526","author":"Auton","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.bbapap.2019.05.002_bb0970","doi-asserted-by":"crossref","first-page":"W545","DOI":"10.1093\/nar\/gky471","article-title":"VarAFT: a variant annotation and filtration system for human next generation sequencing data","volume":"46","author":"Desvignes","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0975","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/humu.23110","article-title":"How to identify pathogenic mutations among all those variations: variant annotation and filtration in the genome sequencing era","volume":"37","author":"Salgado","year":"2016","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0980","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/humu.23427","article-title":"Inferring the effect of genomic variation in the new era of genomics","volume":"39","author":"Chakravorty","year":"2018","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0985","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1021\/acs.biochem.6b00798","article-title":"A general mechanism for the propagation of mutational effects in proteins","volume":"56","author":"Rajasekaran","year":"2017","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbapap.2019.05.002_bb0990","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.sbi.2018.09.004","article-title":"Modulation of allosteric coupling by mutations: from protein dynamics and packing to altered native ensembles and function","volume":"54","author":"Naganathan","year":"2018","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.bbapap.2019.05.002_bb0995","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/humu.23231","article-title":"Whole-protein alanine-scanning mutagenesis of allostery: A large percentage of a protein can contribute to mechanism","volume":"38","author":"Tang","year":"2017","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bbapap.2019.05.002_bb1000","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1042\/BCJ20170304","article-title":"A self-consistent structural perturbation approach for determining the magnitude and extent of allosteric coupling in proteins","volume":"474","author":"Rajasekaran","year":"2017","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbapap.2019.05.002_bb1005","doi-asserted-by":"crossref","first-page":"4779","DOI":"10.1021\/acs.jpclett.7b02021","article-title":"A universal pattern in the percolation and dissipation of protein structural perturbations","volume":"8","author":"Rajasekaran","year":"2017","journal-title":"J. Phys. Chem. Lett."},{"key":"10.1016\/j.bbapap.2019.05.002_bb1010","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/nature11271","article-title":"Protein activity regulation by conformational entropy","volume":"488","author":"Tzeng","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.bbapap.2019.05.002_bb1015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1002452","article-title":"Functional sites induce long-range evolutionary constraints in enzymes","volume":"14","author":"Jack","year":"2016","journal-title":"PLoS Biol."},{"key":"10.1016\/j.bbapap.2019.05.002_bb1020","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1093\/hmg\/ddw091","article-title":"Molecular basis of classic galactosemia from the structure of human galactose 1-phosphate uridylyltransferase","volume":"25","author":"McCorvie","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbapap.2019.05.002_bb1025","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.12814","article-title":"The yin-yang of kinase activation and unfolding explains the peculiarity of Val600 in the activation segment of BRAF","volume":"5","author":"Kiel","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.bbapap.2019.05.002_bb1030","doi-asserted-by":"crossref","first-page":"16903","DOI":"10.1073\/pnas.0407256101","article-title":"Correction of kinetic and stability defects by tetrahydrobiopterin in phenylketonuria patients with certain phenylalanine hydroxylase mutations","volume":"101","author":"Erlandsen","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbapap.2019.05.002_bb1035","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/humu.20097","article-title":"Mechanisms underlying responsiveness to tetrahydrobiopterin in mild phenylketonuria mutations","volume":"24","author":"Pey","year":"2004","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bbapap.2019.05.002_bb1040","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1042\/BJ20120731","article-title":"Human cystathionine beta-synthase (CBS) contains two classes of binding sites for S-adenosylmethionine (SAM): complex regulation of CBS activity and stability by SAM","volume":"449","author":"Pey","year":"2013","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbapap.2019.05.002_bb1045","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1021\/bi301565m","article-title":"Structural and energetic basis of protein kinetic destabilization in human phosphoglycerate kinase 1 deficiency","volume":"52","author":"Pey","year":"2013","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbapap.2019.05.002_bb1050","doi-asserted-by":"crossref","first-page":"5805","DOI":"10.1093\/hmg\/ddu298","article-title":"Tuning intracellular homeostasis of human uroporphyrinogen III synthase by enzyme engineering at a single hotspot of congenital erythropoietic porphyria","volume":"23","author":"ben Bdira","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbapap.2019.05.002_bb1055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032065","article-title":"Molecular insights on pathogenic effects of mutations causing phosphoglycerate kinase deficiency","volume":"7","author":"Chiarelli","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbapap.2019.05.002_bb1060","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/humu.22565","article-title":"Functional studies of tyrosine hydroxylase missense variants reveal distinct patterns of molecular defects in Dopa-responsive dystonia","volume":"35","author":"Fossbakk","year":"2014","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bbapap.2019.05.002_bb1065","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/jnc.14624","article-title":"The quaternary structure of human tyrosine hydroxylase: effects of dystonia-associated missense variants on oligomeric state and enzyme activity","volume":"148","author":"Szigetvari","year":"2018","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbapap.2019.05.002_bb1070","doi-asserted-by":"crossref","first-page":"W382","DOI":"10.1093\/nar\/gki387","article-title":"The FoldX web server: an online force field","volume":"33","author":"Schymkowitz","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbapap.2019.05.002_bb1075","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1016\/j.ijbiomac.2018.07.051","article-title":"Biophysical and functional perturbation analyses at cancer-associated P187 and K240 sites of the multifunctional NADP(H):quinone oxidoreductase 1","volume":"118 (","author":"Pey","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bbapap.2019.05.002_bb1080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/hmg\/ddy323","article-title":"Insight into the specificity and severity of pathogenic mechanisms associated with missense mutations through experimental and structural perturbation analyses","volume":"28","author":"Medina-Carmona","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbapap.2019.05.002_bb1085","doi-asserted-by":"crossref","DOI":"10.1016\/j.tibs.2019.01.003","article-title":"Biophysical and mechanistic models for disease-causing protein variants","author":"Stein","year":"2019","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bbapap.2019.05.002_bb1090","doi-asserted-by":"crossref","first-page":"7382","DOI":"10.1074\/jbc.273.13.7382","article-title":"Disruption of the DT diaphorase (NQO1) gene in mice leads to increased menadione toxicity","volume":"273","author":"Radjendirane","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2019.05.002_bb1095","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/ajcn\/75.4.616","article-title":"High-dose vitamin therapy stimulates variant enzymes with decreased coenzyme binding affinity (increased K(m)): relevance to genetic disease and polymorphisms","volume":"75","author":"Ames","year":"2002","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.bbapap.2019.05.002_bb1100","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.abb.2013.02.015","article-title":"The human flavoproteome","volume":"535","author":"Lienhart","year":"2013","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbapap.2019.05.002_bb1105","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.ijbiomac.2019.01.016","article-title":"Anion-specific interaction with human NQO1 inhibits flavin binding","volume":"126","author":"Pey","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.bbapap.2019.05.002_bb1110","doi-asserted-by":"crossref","DOI":"10.1186\/s12900-016-0052-x","article-title":"A direct interaction between NQO1 and a chemotherapeutic dimeric naphthoquinone","volume":"16","author":"Pidugu","year":"2016","journal-title":"BMC Struct. Biol."},{"key":"10.1016\/j.bbapap.2019.05.002_bb1115","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1073\/pnas.97.7.3177","article-title":"Structures of recombinant human and mouse NAD(P)H:quinone oxidoreductases: species comparison and structural changes with substrate binding and release","volume":"97","author":"Faig","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570963919300822?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570963919300822?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T23:50:02Z","timestamp":1761609002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570963919300822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":223,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S1570963919300822"],"URL":"https:\/\/doi.org\/10.1016\/j.bbapap.2019.05.002","relation":{},"ISSN":["1570-9639"],"issn-type":[{"value":"1570-9639","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NQO1: A target for the treatment of cancer and neurological diseases, and a model to understand loss of function disease mechanisms","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbapap.2019.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}